Formycon Pipeline Climbs To Six As It Adds Two Biosimilars

Partner Teva In Place For Ranibizumab Launch In UK And EU

 
• By Dean Rudge
Arrows up (Sean Prior/Alamy Stock Photo)
2022 is set to be a landmark year for Formycon • Source: Shutterstock (Alamy Stock Photo)

More from Biosimilars

More from Products